Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Blog > 2020 > JOIN CHEMDIV'S RESEARCH NETWORK

JOIN CHEMDIV'S RESEARCH NETWORK

ChemDiv opens you gate to global market.

By partnering with ChemDiv, you gain access to pharma, biotech and academia customers worldwide.

Submit us your catalog of screening compounds and building blocks. Join ChemDiv for sales worldwide.

Please contact us at sb@chemdiv.com

Read also

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

Science & Nature reviews, August 2021 (2)

Science & Nature reviews, August 2021 (2)

These are ChemDiv's reviews on Nature and Science Journal articles.

OCULAR DISEASES SMALL MOLECULES LIBRARY

OCULAR DISEASES SMALL MOLECULES LIBRARY

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept